Successful treatment of solar urticaria with anti-immunoglobulin E therapy.
D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006633:Histamine Antagonists / Q000627:therapeutic use*; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology*; D008875:Middle Aged; D000069444:Omalizumab; D014466:Ultraviolet Rays / Q000009:adverse effects*; D014581:Urticaria / Q000188:drug therapy* / Q000209:etiology
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D006633:Histamine Antagonists; D000069444:Omalizumab; D007073:Immunoglobulin E